Literature DB >> 12452543

Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.

Yossef Itzhak1, Julio L Martin, Syed F Ali.   

Abstract

High doses of methamphetamine (METH) cause the depletion of striatal dopaminergic markers; however, little is known about the behavioral consequences of METH-induced neurotoxicity. In the present study, the authors investigated the effect of a neurotoxic dose of METH (5 mg/kg; every 3 h x3) on the subsequent response of Swiss Webster mice to (a) the psychomotor-stimulating effect of METH and (b) the acquisition and maintenance of conditioned place preference (CPP) by METH. The latter is a paradigm for the assessment of the rewarding properties of abused substances. The administration of the high dose of METH resulted in significant depletion of dopamine (DA) and its metabolites and dopamine transporter (DAT) binding sites in the striatum. The dopaminergic markers were below control levels until the 95th day after METH administration. METH-pretreated mice were sensitized to the psychomotor-stimulating effect of METH (1 mg/kg) as determined on Days 3 and 74 after the initial exposure to the neurotoxic dose of METH. However, the acquisition of CPP by METH (0.5 mg/kg) was markedly reduced in the mice pretreated with the neurotoxic dose of METH compared with the control group. The CPP was maintained for 8 weeks in the control group but not in the METH group. A priming injection of METH (0.5 mg/kg) caused marked reinstatement of place preference in the control group; this response was maintained for three additional weeks. However, the priming injection of METH resulted in diminished place preference in the METH group and the conditioned response dissipated within 3 weeks. These findings suggest that METH-induced striatal dopaminergic neurotoxicity is associated with two opposing and long-lasting behavioral outcomes: (a) sensitization to the psychomotor-stimulating effect of the drug and (b) desensitization to the rewarding properties of the drug. These consequences may be relevant to the psychopathology of METH abuse.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452543     DOI: 10.1016/s0278-5846(02)00257-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  14 in total

1.  Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats.

Authors:  Marley D Kass; Xiangqian Liu; Michael Vigorito; Linda Chang; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-09       Impact factor: 4.147

2.  Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Tomohiro Tatsuta; Kaname Watabe; Yoshio Morita; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-06-22       Impact factor: 3.996

3.  Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway.

Authors:  Lauren K Dobbs; Gregory P Mark
Journal:  Behav Brain Res       Date:  2011-09-17       Impact factor: 3.332

4.  A vaccine against methamphetamine attenuates its behavioral effects in mice.

Authors:  Xiaoyun Y Shen; Therese A Kosten; Angel Y Lopez; Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Drug Alcohol Depend       Date:  2012-09-28       Impact factor: 4.492

5.  Role of mu-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized mice.

Authors:  Lu-Tai Tien; Ing-Kang Ho; Horace H Loh; Tangeng Ma
Journal:  J Neurosci Res       Date:  2007-02-15       Impact factor: 4.164

6.  Impaired formation of stimulus-response, but not action-outcome, associations in rats with methamphetamine-induced neurotoxicity.

Authors:  Jong-Hyun Son; Christine Latimer; Kristen A Keefe
Journal:  Neuropsychopharmacology       Date:  2011-07-20       Impact factor: 7.853

7.  Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.

Authors:  Shannon J Clough; Anthony J Hutchinson; Randall L Hudson; Margarita L Dubocovich
Journal:  Physiol Behav       Date:  2014-05-09

8.  Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice.

Authors:  Curtis E Grace; Tori L Schaefer; Nicole R Herring; Devon L Graham; Matthew R Skelton; Gary A Gudelsky; Michael T Williams; Charles V Vorhees
Journal:  Neurotoxicol Teratol       Date:  2010-01-21       Impact factor: 3.763

9.  Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats.

Authors:  J L Rogers; S De Santis; R E See
Journal:  Psychopharmacology (Berl)       Date:  2008-05-21       Impact factor: 4.530

10.  A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats.

Authors:  Z-X Xi; H K Kleitz; X Deng; B Ladenheim; X-Q Peng; X Li; E L Gardner; E A Stein; J L Cadet
Journal:  Neuroscience       Date:  2009-03-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.